Analysis of P-selectin and integrin GPIIb/IIIa of PLTs revealed that these PLT-activating markers were upregulated in individuals with cancer (Extended Data Fig. 1a,b), suggesting that increased PLT activation contributes to tumor-associated events, such as metastasis and thrombosis. Here, ITGA2B is linked to neoplasm.